Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis
Authors:
- Alice ZwerlingAZAlice Zwerling
- Colleen HanrahanCHColleen Hanrahan
- David W. DowdyDDDavid W. Dowdy
- 9 February 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 183 (5) , 407-414
Abstract
A century's worth of efforts to better understand the epidemiology of tuberculosis (TB) and to develop new vaccines, drugs, preventive interventions, and case-finding approaches have provided important insights and helped to advance the field of epidemiology as a whole. Wade Hampton Frost developed methods for cohort analysis that formed the early basis for adjustment of confounding variables. The streptomycin trial in the United Kingdom in the 1940s introduced random allocation for participants to either the treatment or control group, ensuring blinded treatment assignment and comparable treatment groups, which is now a key element in randomized clinical trials. Research into the bacille Calmette-Guérin vaccine demonstrated the importance of comparative analyses, potential difficulties in generalizability to populations not under study, and the role of meta-analysis for discrepant data—approaches now strongly recommended prior to implementing any novel public health intervention. George Comstock's work on preventive therapy for TB demonstrated the use of epidemiologic methods to evaluate interventions on a population level. Finally, studies from the Consortium to Respond Effectively to the AIDS/TB Epidemic focused on the evaluation of real-world effectiveness and of targeting of high-risk subpopulations. In this article, we discuss how TB research in each of these domains has helped to advance epidemiologic thinking and methodology over the past 100 years.Keywords
This publication has 38 references indexed in Scilit:
- Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?PLOS Pathogens, 2012
- Tuberculosis vaccines: beyond bacille Calmette–GuérinPhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
- Thibela TB: Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South AfricaContemporary Clinical Trials, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trialTrials, 2008
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational StudiesPLOS Medicine, 2008
- Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy interventionClinical Trials, 2007
- The MRC randomized trial of streptomycin and its legacy: a view from the clinical front lineJournal of the Royal Society of Medicine, 2006
- Applying Experiences from Trials of Bacille Calmette-Guérin VaccineClinical Infectious Diseases, 2000
- Uranium Mining and Lung Cancer in Navajo MenNew England Journal of Medicine, 1984